Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Trends and disparities in thyroid cancer related mortality from 1999 to 2023: about CDC WONDER database analysis.

BMC endocrine disorders·2026

Same author

Perceptions, knowledge, and access to the HPV vaccine among parents and healthcare providers in South Quito, Ecuador in 2025: A qualitative study.

Global public health·2026

Same author

Genomic Characteristics of Leiomyosarcoma: An AACR Project GENIE Study.

Anticancer research·2026

Same author

Understanding mortality trends in patients with uterine malignancies from 1999 to 2023 utilizing the CDC WONDER database.

Journal of gynecologic oncology·2026

Same author

Trends and Disparities in Secondary Malignant Neoplasms of the Bone in the United States: The WONDER Study.

Cancers·2026

Same author

Citrobacter Causing Septic Arthritis: A Case Report.

Infectious diseases & immunity·2026

Search research articles

Related Experiment Video

Updated: Jul 25, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Genomic Characteristics of Bladder Cancer: An AACR Project GENIE Study.

John Paul Braun¹, Kenneth A D Palattao¹, Elijah Torbenson¹

¹School of Medicine, Creighton University, Omaha, NE 68178, USA.

International Journal of Molecular Sciences

|December 11, 2025

Summary

Bladder cancer exhibits significant genomic diversity. Key mutations in genes like TP53 and FGFR3 vary by demographics, revealing distinct molecular subtypes crucial for targeted therapy development.

Keywords:

AACR Project GENIE bladder cancer copy number alterations demographic disparities genomic profiling somatic mutations targeted therapy urothelial carcinoma

More Related Videos

Cell-Free DNA Integrity Analysis in Urine Samples

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

Related Experiment Videos

Last Updated: Jul 25, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Cell-Free DNA Integrity Analysis in Urine Samples

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

Area of Science:

Oncology
Genomics
Cancer Research

Background:

Bladder and urothelial carcinoma display substantial genomic heterogeneity.
Understanding this diversity is critical for advancing treatment strategies.

Purpose of the Study:

To perform comprehensive genomic profiling of a large bladder cancer cohort.
To identify demographic associations, mutation frequencies, and copy number alterations.
To explore co-occurrence and mutual exclusivity patterns for molecular subtype discovery.

Main Methods:

Retrospective analysis of 4631 tumor samples from the AACR Project GENIE database.
Comprehensive genomic profiling including mutation analysis and copy number assessment.
Statistical analysis of demographic associations, mutation frequencies, and survival correlations (p<0.05).

Main Results:

Frequent mutations identified in TP53, TERT, KDM6A, KMT2D, ARID1A, and FGFR3.
Mutation frequencies showed variations by sex and race, with specific alterations enriched in female and Asian patients.
Distinct co-occurrence (e.g., TP53/RB1) and mutual exclusivity (e.g., TP53/FGFR3) patterns identified, defining molecular subtypes.

Conclusions:

Bladder cancer presents extensive genomic heterogeneity.
Molecular stratification is clinically important.
Findings support further research into targeted therapies based on identified molecular subtypes.